Cellerix

Eduardo has more than 18 years experience in the pharmaceutical industry. His professional career includes several senior management positions at Sanofi-Aventis, including Vice President for Latin America, where he was in charge of more than 2000 employees and oversaw sales of more than €1 billion. At Sanofi-Aventis he also held positions such as Marketing and Sales Manager for Europe and General Manager for Belgium. He also worked for 7 years in SmithKline Beecham in sales positions both nationally and internationally. Eduardo holds a degree in Business Administration and an MBA (INSEAD, Fontainebleau, France). In addition, Eduardo Bravo is a member of the Board of Directors of Cellerix.

Claudia has more than 10 years of experience in corporate finance. After completing her PhD degree, she joined the Corporate Finance Department at Deloitte & Touche in Milan. She then moved to Apax Partners in Madrid where she was responsible for setting up and implementing M&A transactions. She was then made Chief Financial Officer at Aquanima (Grupo Santander). Claudia has a degree in Economics from the University of Bocconi, Italy, and a PhD in Business Administration awarded by Bocconi University and Visiting Fellow in financial risk management at Harvard University.

Jorge has worked for more than 20 years in biotechnology. He started as a basic research scientist with positions both in Spain and in the NIH (USA). After being awarded his MBA at the Instituto de Empresa, Madrid, he was General Manager of Pharmagen, a biotech company focused on novel diagnostic technologies. He held the position of Vice Director at the Spanish National Cancer Research Center (Centro Nacional de Investigaciones Oncológicas-CNIO) for 5 years. He has participated as an expert in a large number of industry forums on technology innovation and R&D both in the public and private sectors. Jorge holds a degree in Medicine and a PhD in Biochemistry from the Universidad Complutense in Madrid and an MBA from the Instituto de Empresa, Madrid.

During his 15 years working as a researcher in international academic institutions, Dirk acquired extensive scientific knowledge, which is reflected in more than 20 high-impact publications. He received his PhD in Immunology and focused on molecular development biology and stem cell research during his 6 years work at the Salk Institute for Biological Science, La Jolla, California (USA). Dirk has a degree and PhD in Biology, both awarded by the University of Hannover (Germany), and an MBA from the Instituto de Empresa, Madrid.

In 1988, Guillermo and other partners founded the first Clinical Research Organisation in Spain, CIBEST (Centro de Investigación y Bioestadística). After selling the CRO to the Swiss multinational SGS (Societé General de Surveillance), Guillermo held the post of Assistant Director General and Director of the Business Development Unit. In 2003, Sellers joined Serono (currently Merck Serono) as the Medical Director for Spain and Portugal, where he was in charge of research and providing support for marketing and sales activities in these two countries. In addition to his more than 20 years of professional experience, Guillermo is the author of numerous publications and scientific articles in national and international magazines, as well as of several specialised books. Guillermo has a degree in Medicine and Surgery and PhD in Medicine, both awarded by the Autonoma University of Madrid, and an holds a Masters in General Management from the IESE, Madrid.

Carlo has several years experience in the development of diagnostic and therapeutic products. Previously, he was head of the clinical division of Miltenyi Biotec in Spain working on cell therapy based on selection of hematopoietic stem cells. He has also worked at Chiron Diagnostics in the implementation of novel monitoring systems for HIV patients, and then at Bayer Diagnostics. He has also been in charge of Marketing Development for PCR molecular diagnostic systems at Pharmagen and a biotechnology specialist at Izasa. Carlo has a degree in Biology from the Universidad Autónoma in Madrid.

María has an intensive research career behind her in the Spanish National Research Council (Consejo Superior de Investigaciones Científicas-CSIC) and is a winner of the international Julia Bodmer Award. Her international experience includes work in the Mayo Clinic (MN, USA) and the Leiden University Medical Center (Netherlands). She specialised in drug development and regulatory affairs in the field of advanced therapies. She has experience in different positions in the area of regulatory affairs. She is an active participant in several technical working groups and lobbies for European industry in advanced therapies and is currently an expert consultant in this field for the European Medicines Agency (EMEA). María graduated in Pharmacy from the University of Granada and obtained her PhD in Pharmacy from the CSIC.

Gemma has 5 years of experience working in research in the field of stem cells and in specialist laboratories. Since joining Cellerix, she and her team have reached some key milestones, such as obtaining accreditation for Cellerix as a pharmaceutical company by the AEMPS (Spanish Medicines Agency) and the management of the clinical trials undertaken by the company. Gemma is a Biology graduate from the Universidad Complutense in Madrid and has a PhD in Biology awarded by the University of Alcalá de Henares, Spain.

Mario was previously the Technical Director of the Spanish National Cancer Research Center (Centro Nacional de Investigaciones Oncológicas-CNIO), where he was responsible for coordinating the infrastructure of the center, including IT, maintenance, biosecurity, and management of the installations and building for scientific use. He is also an Associate Professor in the Department of Applied Mathematics in the Faculty of Biological Sciences of the Universidad Complutense in Madrid. Mario is a Biology graduate from the Universidad Complutense in Madrid and has a Diploma in IT Management from the IC.

Claudia began her professional career in the WestLB AG investment bank (Germany), where she held a number of positions in her 5-year stay, the most recent being in the M&A Department, where she directed projects in several industries, including the pharmaceutical industry and biotechnology. Claudia has degrees in International Business Studies from the Universidad Pontificia Comillas (ICADE) and the FDH Reutlingen (Germany), and an MBA from the Instituto de Empresa, Madrid.

Miguel Ángel has more than 10 years experience providing legal advice to technological companies in France, the UK and Spain. Miguel Ángel was Legal Director of the Genetrix Group in Spain and the Vectone Group in the United Kingdom. The Vectone Group operates in the telecommunications sector. Miguel Ángel has a degree in Law from the University of Murcia, a master’s degree in International Trade Law from the University of Paris X Nanterre and a master’s degree in European Union Law from the University Carlos III in Madrid. He has also taken specialist professional development courses from the BPP Law School in London and has qualified as a British solicitor.

Miguel brings his experience of 15 years in the pharmaceutical industry, including CRO experience (Parexel) as much as multiple pharmaceutical companies, such as Pharmacia Corp./Pfizer (France) and Pharmacia & Upjohn (Milan), for which he worked as Project Manager in different therapeutical areas, including Oncology and Gastroenterology. He has extensive experience in the coordination of clinical trials across all development phases including the management of multidisciplinary teams, regulatory affairs, project planning and implementation, resource management. Within his previous position as Senior Manager, Clinical Operations in PDL BioPharmas, he was responsible for the management of Gastroenterology projects during 4 years, with primary focus on European activities. Miguel has a degree in Business Management from the University of Cologne (Germany).